<qa>  What is the STUDY of 3 PRIME-BOOST REGIMENS FOR ESAFETY, TOLERABILITY AND IMMUNOGENICITY STUDY OF 3 PRIME-BOOST REGIMENS FOR EBOLA VACCINES AD26.ZEBOVMVA-BN-FILO IN HEALTHY ADULTS, CHILDREN AND HUMAN IMMUNODEFICIENCY VIRUS POSITIVE HIV ADULTS: 